Catalyst Brief

← Calendar

Readoutin 14d

Materia Medica Holding — Raphamin

Phase 3 primary completion: Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis.

Date
Dec 2026
Type
Readout
Indication
Cystitis Chronic

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.